Skip to content

Clinical Efficacy Observation of Auricular Point Pressing Combined with Qili Qiangxin Capsules in the Treatment of Chronic Heart Failure of Yang Deficiency and Water Flooding Pattern

Clinical Efficacy Observation of Auricular Point Pressing Combined with Qili Qiangxin Capsules in the Treatment of Chronic Heart Failure of Yang Deficiency and Water Flooding Pattern

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001409
Enrollment
Unknown
Registered
2025-07-15
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure of the yang - deficiency and water - flooding type.

Interventions

observation group:Give routine Western medicine treatment Qili Qiangxin Capsules and auricular point pressing.
control group:Give routine Western medicine treatment and Qili Qiangxin Capsules.

Sponsors

Shanghai Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the (Chinese and Western medicine) and syndrome type criteria for chronic heart failure of the yang deficiency and water flooding type; (2) Those aged between 18 and 90 years old regardless of gender; (3) Chronic heart failure patients with NYHA cardiac function classification of grade II to III; (4) Those with a left ventricular ejection fraction less than 40% (HFrEF); (5) Those who are informed about this study voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe underlying diseases or mental illnesses; (2) Patients allergic to the drugs used in this study or allergic to the adhesive tape for application or Vaccaria seeds; (3) Patients with severe infections or active diseases such as rheumatic fever bacterial endocarditis etc.; (4) Patients who cannot strictly comply with the requirements of this trial or are currently participating in other drug clinical trials; (5) Women who are pregnant planning to become pregnant or breastfeeding; (6) Patients who are not adaptable to auricular point sticking therapy; (7) Patients who do not agree to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Score of Traditional Chinese Medicine Single Symptoms and Syndromes;

Secondary

MeasureTime frame
Calf circumference before and after admission;Minnesota Living with Heart Failure Questionnaire (MLHFQ) Score;Cardiac function indicators: NT - proBNP left ventricular ejection fraction (LVEF) 6 - minute walk distance;Body weight before and after admission;

Countries

China

Contacts

Public ContactWu Ke

Shanghai Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

17355268267@163.cm+86 173 5526 8267

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026